|
Status |
Public on Mar 19, 2017 |
Title |
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
28439950 |
|
Submission date |
Mar 18, 2017 |
Last update date |
Aug 13, 2018 |
Contact name |
Jae-Kyung Won |
E-mail(s) |
jkwon@snuh.org
|
Organization name |
Seoul National University Hospital
|
Street address |
101 Daehak-ro
|
City |
Seoul |
ZIP/Postal code |
110-744 |
Country |
South Korea |
|
|
Platforms (2) |
GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
GPL10904 |
Illumina HumanHT-12 V4.0 expression beadchip (gene symbol) |
|
Samples (24)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE96792 |
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma [Hep3B] |
GSE96793 |
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma [HepG2] |
GSE96794 |
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma [Huh7] |
GSE96795 |
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma [SNU761] |
|
Relations |
BioProject |
PRJNA379711 |